Patents by Inventor Robert Andrew Price

Robert Andrew Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF PRODUCTION OF BICYCLIC HYDROCARBONS
    Publication number: 20250197326
    Abstract: A method for producing a bicyclic hydrocarbon molecule includes oxidizing a terpene molecule to provide a first intermediate compound, wherein the first intermediate compound includes an aldehyde functional group, reacting the first intermediate compound with a 1,3-diene molecule to form a second intermediate compound including the aldehyde functional group, and reducing the second intermediate compound to yield a first bicyclic hydrocarbon molecule, wherein reducing the second intermediate compound includes removing the aldehyde functional group.
    Type: Application
    Filed: December 18, 2024
    Publication date: June 19, 2025
    Applicant: CleanJoule, Inc.
    Inventors: Matthew Raymond Crawley, Oyvind Hatlevik, Robert Andrew Price, Mukund Karanjikar, Timothy Raymond Cook
  • Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
    Patent number: 10253089
    Abstract: A delivery system that includes a recombinantly synthesized protein polymer with protease cleavage sites such as matrix metalloproteinase responsive sequences engineered within the protein polymer. The system may be used to treat cancer, wounds, or pathological conditions in other tissues that express excess protease relative to healthy tissue.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: April 9, 2019
    Assignee: University of Utah Research Foundation
    Inventors: Hamidreza Ghandehari, Joseph Cappello, Jordan Frandsen, Joshua Gustafson, Khaled Greish, Robert Andrew Price
  • MATRIX METALLOPROTEINASE CLEAVABLE PROTEIN POLYMERS FOR CANCER GENE THERAPY
    Publication number: 20150152165
    Abstract: A delivery system that includes a recombinantly synthesized protein polymer with protease cleavage sites such as matrix metalloproteinase responsive sequences engineered within the protein polymer. The system may be used to treat cancer, wounds, or pathological conditions in other tissues that express excess protease relative to healthy tissue.
    Type: Application
    Filed: May 30, 2013
    Publication date: June 4, 2015
    Inventors: Hamidreza Ghandehari, Joseph Cappello, Jordan Frandsen, Joshua Gustafson, Khaled Greish, Robert Andrew Price